curacin D: RN given for (1alpha(R*(12,5E,7E,11R*)),2beta)-isomer; isolated from Lyngbya majuscula; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 10546404 |
| CHEBI ID | 187110 |
| MeSH ID | M0300415 |
| Synonym |
|---|
| curacin d |
| 4-[(1z,5e,7e)-11-methoxytetradeca-1,5,7,13-tetraenyl]-2-[(1r,2s)-2-methylcyclopropyl]-4,5-dihydro-1,3-thiazole |
| CHEBI:187110 |
| c22h33nos |
| Class | Description |
|---|---|
| organosulfur compound | An organosulfur compound is a compound containing at least one carbon-sulfur bond. |
| organonitrogen compound | Any heteroorganic entity containing at least one carbon-nitrogen bond. |
| heterocyclic compound | A cyclic compound having as ring members atoms of at least two different elements. |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] | |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||